Status:
COMPLETED
Prognostic Value of Biochemical Markers in Cerebrospinal Fluid for Functional Outcome of Spinal Cord Injured Patients
Lead Sponsor:
Azienda Usl di Bologna
Conditions:
Spinal Cord Injuries
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The project is aimed to develop predictive indices of spinal cord injury severity through the analysis of cerebrospinal fluid of patient collected during acute injury.
Eligibility Criteria
Inclusion
- presence of cervical and thoracic Spinal Cord Injury
- need to be submitted to spine surgical stabilization with posterior approach
Exclusion
- prior to recruitment, in the acute phase, treatment with steroid therapy
Key Trial Info
Start Date :
August 24 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2017
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01861808
Start Date
August 24 2013
End Date
August 31 2017
Last Update
October 19 2017
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Montecatone Rehabilitation Institute SpA
Imola, Bologna, Italy, 40026
2
Centro Interdipartimentale Ricerca Industriale Università degli Studi
Ozzano Monferrato, Bologna, Italy, 40064
3
UOC Rianimazione CO e 118 Ospedale Maggiore AUSL
Bologna, Italy, 40133
4
UOSD Chirurgia Vertebrale di Urgenza e del Trauma Ospedale Maggiore AUSL
Bologna, Italy, 40133